Skip to main content
Dermatology and Therapy logoLink to Dermatology and Therapy
. 2022 Sep 13;12(10):2295. doi: 10.1007/s13555-022-00798-8

Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea

Rongli Yang 1, Chang Liu 2, Wenli Liu 1, Jintian Luo 3, Shaoli Cheng 4, Xin Mu 1,
PMCID: PMC9515297  PMID: 36098878

Correction to: Dermatol Ther (Heidelb) 10.1007/s13555-022-00784-0

Authors would like to correct the error on Fig. 5 caption.

Fig. 5 Dermatology life quality scores before and 1, 3, and 6 months after treatment (##P < 0.01 versus baseline, *P < 0.05 versus 3 months, ▼▼P < 0.01 versus 3 months).

revised to

Fig. 5 Dermatology life quality scores before and 1, 3, and 6 months after treatment (##P < 0.01 versus baseline, *P < 0.05 versus 1 months, ▼▼P < 0.01 versus 3 months).

The original article has been corrected.


Articles from Dermatology and Therapy are provided here courtesy of Springer

RESOURCES